Milnacipran is a serotonin–norepinephrine reuptake inhibitor used in the clinical treatment of fibromyalgia.
This report contains market size and forecasts of Milnacipran in global, including the following market information:
Global Milnacipran Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Milnacipran Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Milnacipran companies in 2021 (%)
The global Milnacipran market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Milnacipran include Neuraxpharm, Caming Pharmaceutical, LGM Pharma, Toronto Research Chemicals, RG, JRC, AK Scientific, NAMIKI SHOJI and Asahi Kasei, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Milnacipran manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Milnacipran Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Milnacipran Market Segment Percentages, by Type, 2021 (%)
Powder
Crystal
Granule
Global Milnacipran Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Milnacipran Market Segment Percentages, by Application, 2021 (%)
Tablet
Capsule
Global Milnacipran Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Milnacipran Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Milnacipran revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Milnacipran revenues share in global market, 2021 (%)
Key companies Milnacipran sales in global market, 2017-2022 (Estimated), (MT)
Key companies Milnacipran sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Neuraxpharm
Caming Pharmaceutical
LGM Pharma
Toronto Research Chemicals
RG
JRC
AK Scientific
NAMIKI SHOJI
Asahi Kasei
Hangzhou Rongda Pharm & Chem
Novadoz Pharmaceuticals